Heart failure disease management program: A review

por AlHabeeb, Waleed
Publicado 2022

Continuation of Angiotensin Converting Enzyme Inhibitors in Acute Heart Failure

por AlHabeeb, Waleed, Hayajneh, Ahmad
Publicado 2021

Management of end-stage heart failure: a perspective on the Arab Gulf states

por Al Habeeb, Waleed, Stewart, Garrick C., Mudge, Gilbert H.
Publicado 2009

Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

por AlHabeeb, Waleed, Mrabeti, Sanaa, Abdelsalam, Ahmed Adel Ibrahim
Publicado 2021

Attitude of the Saudi community towards heart donation, transplantation, and artificial hearts

por AlHabeeb, Waleed, AlAyoubi, Fakhr, Tash, Adel, AlAhmari, Leenah, AlHabib, Khalid F.
Publicado 2017

Saudi Heart Association Position Statement on the Use of Biomarkers for the Management of Heart Failure and Acute Coronary Syndrome

por AlHabeeb, Waleed, Tash, Adel Abdulkader, Almutari, Fawaz, Al Ghalayini, Kamal, Alqaseer, Maryam, Alshamiri, Mostafa, Kharabsheh, Suleiman, AlKashkari, Wail
Publicado 2022

Pulmonary arterial hypertension in Saudi patients with systemic sclerosis: Clinical and hemodynamic characteristics and mortality

por Al Otair, Hadil AK., Idrees, Majdy M., Saleemi, Sarfraz A., Eltoukhy, Ahmed M., Alhijji, Ali A., Al Habeeb, Waleed A., Omair, Mohammed A.
Publicado 2019

Mutation in FBXO32 causes dilated cardiomyopathy through up-regulation of ER-stress mediated apoptosis

por Al-Yacoub, Nadya, Colak, Dilek, Mahmoud, Salma Awad, Hammonds, Maya, Muhammed, Kunhi, Al-Harazi, Olfat, Assiri, Abdullah M., Al-Buraiki, Jehad, Al-Habeeb, Waleed, Poizat, Coralie
Publicado 2021

FBXO32, encoding a member of the SCF complex, is mutated in dilated cardiomyopathy

por Al-Yacoub, Nadya, Shaheen, Ranad, Awad, Salma Mahmoud, Kunhi, Muhammad, Dzimiri, Nduna, Nguyen, Henry C., Xiong, Yong, Al-Buraiki, Jehad, Al-Habeeb, Waleed, Alkuraya, Fowzan S., Poizat, Coralie
Publicado 2016

2023 National Heart Center/Saudi Heart Association Focused Update of the 2019 Saudi Heart Association Guidelines for the Management of Heart Failure

por Al Habeeb, Waleed, Tash, Adel, Elasfar, Abdelfatah, Almasood, Ali, Bakhsh, Abeer, Elshaer, Fayez, Al Ayoubi, Fakhr, AIghalayini, Kamal Waheeb, AlQaseer, Maryam Mohammed, Alhussein, Mosaad, Almogbel, Osama, AlSaif, Shukri Merza, AlHebeshi, Yahia
Publicado 2023

Saudi Heart Association Guidelines on Best Practices in the Management of Chronic Coronary Syndromes

por AlShammeri, Owayed, AL Saif, Shukri, Al Shehri, Halia, Alasng, Mirvat, Qaddoura, Fatema, Al Shehri, Mohammad, Turkistani, Yosra, Tash, Adel, Alharbi, Walid, Al Qahtani, Fahad, Diaz, Rafael, Mahaimeed, Wael, Al habeeb, Waleed, Alfaraidy, Khalid
Publicado 2022

Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress

por Awad, Salma, Al-Haffar, Kamar Mohamed Adib, Marashly, Qussay, Quijada, Pearl, Kunhi, Muhammad, Al-Yacoub, Nadya, Wade, Fallou S, Mohammed, Shamayel Faheem, Al-Dayel, Fouad, Sutherland, George, Assiri, Abdullah, Sussman, Mark, Bers, Donald, Al-Habeeb, Waleed, Poizat, Coralie
Publicado 2015

The prognostic impact of hyperglycemia on clinical outcomes of acute heart failure: Insights from the heart function assessment registry trial in Saudi Arabia

por Aljohar, Alwaleed, Alhabib, Khalid F., Kashour, Tarek, Hersi, Ahmad, Al Habeeb, Waleed, Ullah, Anhar, Elasfar, Abdelfatah, Almasood, Ali, Ghabashi, Abdullah, Mimish, Layth, Alghamdi, Saleh, Abuosa, Ahmed, Malik, Asif, Hussein, Gamal Abdin, Al-Murayeh, Mushabab, AlFaleh, Hussam
Publicado 2018

Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry)

por AlFaleh, Hussam, Elasfar, Abdelfatah A., Ullah, Anhar, AlHabib, Khalid F., Hersi, Ahmad, Mimish, Layth, Almasood, Ali, Al Ghamdi, Saleh, Ghabashi, Abdullah, Malik, Asif, Hussein, Gamal A., Al-Murayeh, Mushabab, Abuosa, Ahmed, Al Habeeb, Waleed, Kashour, Tarek S.
Publicado 2016

Saudi Heart Association (SHA) guidelines for the management of heart failure

por AlHabeeb, Waleed, Al-Ayoubi, Fakhr, AlGhalayini, Kamal, Al Ghofaili, Fahad, Al Hebaishi, Yahya, Al-Jazairi, Abdulrazaq, Al-Mallah, Mouaz H., AlMasood, Ali, Al Qaseer, Maryam, Al-Saif, Shukri, Chaudhary, Ammar, Elasfar, Abdelfatah, Tash, Adel, Arafa, Mohamed, Hassan, Walid
Publicado 2019

One-year real-world outcomes for patients undergoing transcatheter mitral valve repair: the Gulf MTEER registry (GULF Mitral Transcatheter Edge to Edge Repair)

por Alasnag, Mirvat, Bokhari, Fayez, Almoghairi, Abdulrahman, Marri, Khaled, Alenezi, Abdullah, AlHarbi, Waleed, Alanazi, Nouf, Amin, Haitham, Noor, Hussam, Al-Shaikh, Shereen, Bardowli, Fawaz, Lawati, Hatim Al, AlFaraidy, Khalid, AlShehri, Mohammed, Tash, Adel, AlHabeeb, Waleed, Balghith, Mohammed, Thabane, Michael, Thabane, Lehana, Al-Shaibi, Khaled
Publicado 2023

Deletion of low molecular weight protein tyrosine phosphatase (Acp1) protects against stress‐induced cardiomyopathy

por Wade, Fallou, Quijada, Pearl, Al‐Haffar, Kamar Mohamed Adib, Awad, Salma Mahmoud, Kunhi, Muhammad, Toko, Haruhiro, Marashly, Qussay, Belhaj, Karim, Zahid, Israa, Al‐Mohanna, Falah, Stanford, Stephanie M, Alvarez, Roberto, Liu, Yingge, Colak, Dilek, Jordan, Maria C, Roos, Kenneth P, Assiri, Abdullah, Al‐Habeeb, Waleed, Sussman, Mark, Bottini, Nunzio, Poizat, Coralie
Publicado 2015

Dapagliflozin for heart failure according to body mass index: the DELIVER trial( )

por Adamson, Carly, Kondo, Toru, Jhund, Pardeep S, de Boer, Rudolf A, Cabrera Honorio, Jose Walter, Claggett, Brian, Desai, Akshay S, Alcocer Gamba, Marco Antonio, Al Habeeb, Waleed, Hernandez, Adrian F, Inzucchi, Silvio E, Kosiborod, Mikhail N, Lam, Carolyn S P, Langkilde, Anna Maria, Lindholm, Daniel, Bachus, Erasmus, Litwin, Sheldon E, Martinez, Felipe, Petersson, Magnus, Shah, Sanjiv J, Vaduganathan, Muthiah, Nguyen Vinh, Pham, Wilderäng, Ulrica, Solomon, Scott D, McMurray, John J V
Publicado 2022